Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px

Document › Details

Calliditas Therapeutics AB. (7/2/20). "Press Release: Exercise of Over-allotment Option and End of the Stabilization Period".

	Region	United States (USA)
	Organisation	Calliditas Therapeutics AB (Nasdaq Stockholm: CALTX)
	Group	Calliditas Therapeutics (Group)
	Organisation 2	Nasdaq Global Select Market
	Today	Nasdaq Global Market
	Group	Nasdaq OMX (Group)
	Product	investment banking
	Product 2	Nefecon®
	Index term	Calliditas Therapeutics–SEVERAL: investment, 202005–202007 US IPO $81m+$6.9m with w 8.3m+707k common shares as ADSs at Nasdaq Global Market
	Person	Aguiar-Lucander, Renée (Pharmalink AB 201708 CEO)
	Person 2	Widell, Mikael (Pharmalink AB 201708– Head of Communications before Cord Communications + Nordic Capital)

Original document
accessed by [iito] on 2020-08-26

Record changed: 2020-10-21

Picture [iito] Plain Stupid Simple 650x80px

More documents for Calliditas Therapeutics (Group)

[1] Calliditas Therapeutics AB. (8/25/20). "Press Release: Calliditas Appoints Group General Counsel"....
[2] Calliditas Therapeutics AB. (8/13/20). "Press Release: Calliditas Announces Agreement to Acquire Controlling Interest in Genkyotex SA"....
[3] Calliditas Therapeutics AB. (7/24/20). "Press Release: Calliditas Reorganizes Its Management Team"....
[4] Calliditas Therapeutics AB. (6/5/20). "Press Release: Calliditas Therapeutics Prices Its Initial Public Offering on The Nasdaq Global Select Market in the United States"....
[5] Calliditas Therapeutics AB. (5/14/20). "Press Release: Calliditas Publicly Files Registration Statement with SEC for a Proposed Initial Public Offering in the United States"....
[6] Calliditas Therapeutics AB. (6/10/19). "Press Release: Calliditas Therapeutics and Everest Medicines Enter into an Agreement to Develop and Commercialize Nefecon for IgA Nephropathy in Greater China and Singapore"....
[7] Calliditas Therapeutics AB. (4/5/19). "Press Release: Elmar Schnee and Diane Parks Proposed as New Board Members of Calliditas Therapeutics". Stockholm....
[8] Calliditas Therapeutics AB. (1/8/19). "Press Release: Calliditas Therapeutics Appoints Andrew Udell to VP Commercial, North America"....
[9] Calliditas Therapeutics AB. (11/20/17). "Press Release: Surrogate Marker and Design of Calliditas Therapeutics’ IgA Nephropathy Phase 3 Study Agreed with the FDA". Stockholm....
[10] Calliditas Therapeutics AB. (11/15/17). "Press Release: Pharmalink Is Renamed Calliditas Therapeutics"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]